Mark Allenby

Dr Mark C Allenby is a Senior Lecturer in Biomedical Engineering within UQ's School of Chemical Engineering, and an emerging leader in haematopoietic and vascular tissue engineering. Mark has been awarded nearly $5m of funding as chief investigator across 25 competitive funding rounds in 8 years. Mark received a PhD and MSc in chemical engineering from Imperial College London, UK and bachelors degrees in mathematics and chemistry from Pepperdine University, USA. Since his PhD, Mark has been awarded ten consecutive years of clinical, fundamental, and industrial research fellowships in the field of tissue engineering (ARC FoR 400311): - Heart Foundation Future Leader Fellowship (2025 - 2029). Engineering vessels to grow and test cell therapies. - Australian Research Council DECRA Fellowship (2022 - 2025). Cell therapy manufacturing in vacularised bioreactors. - Advance Queensland Industry Research Fellowship (2019 - 2022). Peripheral and cerebro-vascular tissue biofabrication. Research Interests: Mark leads the BioMimetic Systems Engineering (BMSE) Lab. In the BMSE Lab, we combine Tissue Engineering, Biomedical Image Analysis, and Computational Biology to study and solve medical problems using advanced cell culture and computer models. Our work aligns with bioprocess engineering fundamentals, cell therapy or medical device manufacturing, and clinical collaborators in Haematology and Vascular Surgery. We are always looking for excellent postdoctoral, PhD, MPhil, and honours researchers, funded positions are advertised on our lab website. Academic Interests: Mark is the 2024-2027 deputy director of higher degree research (HDR) students in UQ ChE. Mark was the 2021-2024 Convener of UQ's Biomedical Engineering (BME) major, ranked #1 in Australia. BME at UQ spans schools of Chemical Engineering (ChE; #1 in Australia), Electrical Engineering, and Mechanical Engineering. Mark is the creator and coordinator of Quantitative Methods in Biomedical Engineering, and is a lecturer of Biomanufacturing Technology and Process Modeling & Dynamics. Mark has taught courses in biomaterials, process modelling, and reaction engineering in ChE and BME departments at universities in the UK and Australia. Mark's recent leadership is exhibited by the: - 2025 Invited Speaker to the International Society of Cell Therapies - ANZ - 2025 Faculty Nominee for UQ's Emerging HDR Supervisor of the Year - 2025 Theme Lead of Preclinical Models: UQ Centre for Cardiovascular Health and Research - 2025, 2024, 2023, 2022 Executive Board Member of ASBTE - 2025 Chair of ASBTE's Annual Conference - 2025 Cell and Gene Catalyst Workforce Committee Expert - 2025, 2024 Friends of CCRM Australia Industry Advisory Network - 2024 UQ Foundation Research Excellence Award - 2024 UQ EAIT EMCR Industry Engagement Award - 2024 ASBTE Emerging Leadership Award - 2023 TERMIS-AP Young Investigator Award - 2023 RegMedNet Rising Star Finalist Biofabrication, Biomaterials, Biomedical engineering, Biomedical imaging, Computational physiology, Engineering, Tissue engineering

[2025] Fabricating microfluidic co-cultures of immortalized cell lines uncovers robust design principles for the simultaneous formation of patterned, vascularized, and stem cell-derived adipose tissue. Murphy, Ashley R., Franco, Rose Ann and Allenby, Mark C. (2025). Small, 21 (32) e2501834, e2501834. doi: 10.1002/smll.202501834 [2026] Milk osteopontin alters the infant microbiome to drive DC hematopoiesis and disease tolerance. Howard, Daniel R., Rashid, Ridwan B., Ahmed, Tufael, Namubiru, Patricia, Sohel Rana, Md., Wilkins, Tyler, Morrow, Joshua, Creek, Darren J., Franco, Rose Ann, Allenby, Mark C., Turner, Declan L., Werder, Rhiannon B., Manna, Sam, Satzke, Catherine, Lim, Yenkai, Sun, Jiarui, Dennis, Paul G., Yadav, Anushka, Kueh, Andrew J., Chung, Cheong Kwong, Forbes-Blom, Elizabeth,